{"id":"NCT01235962","sponsor":"Novartis Pharmaceuticals","briefTitle":"A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)","officialTitle":"A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Pazopanib as Adjuvant Therapy for Subjects With Localized or Locally Advanced RCC Following Nephrectomy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-11-30","primaryCompletion":"2015-10-15","completion":"2019-04-15","firstPosted":"2010-11-08","resultsPosted":"2020-11-23","lastUpdate":"2020-11-23"},"enrollment":1538,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Renal Cell Carcinoma (RCC)","Cancer"],"interventions":[{"type":"DRUG","name":"pazopanib","otherNames":["PZP034"]},{"type":"DRUG","name":"placebo","otherNames":[]},{"type":"DRUG","name":"pazopanib","otherNames":["Votrient"]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"pazopanib","type":"EXPERIMENTAL"},{"label":"placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This randomized Phase III study is to evaluate whether pazopanib compared with placebo can prevent or delay recurrence of kidney cancer in patients with moderately high or high risk of developing recurrence after undergoing kidney cancer surgery.","primaryOutcome":{"measure":"Disease-free Survival (DFS) With Pazopanib 600 mg Daily Initial Dose vs. Placebo","timeFrame":"approximately 5 years","effectByArm":[{"arm":"ITT Pazopanib 600 mg","deltaMin":null,"sd":null},{"arm":"ITT Placebo 600 mg","deltaMin":null,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.1649"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":19},"locations":{"siteCount":312,"countries":["United States","Argentina","Austria","Belgium","Brazil","Canada","Chile","China","Czechia","Denmark","France","Germany","Greece","Hungary","Ireland","Israel","Italy","Japan","Luxembourg","Poland","Russia","Slovakia","South Korea","Spain","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["20100962","33461782"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":44,"n":198},"commonTop":["Diarrhoea","Hypertension","Fatigue","Nausea","Hair colour changes"]}}